Evidence map›Paper›PMID 42824263›Full record

ArticleEJHaem2026

A Retrospective Review of 1821 Cases of Eosinophilia in a Single-Center Study in Eastern China.

Yanan Ma, Linlin Wang, Yuexin Cheng, Xiaofei Yang, Suning Chen

Abstract read
In one paragraph

Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yanan Ma *National Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou People's Republic of China.
Linlin Wang *Department of Hematology The First people's Hospital of Yancheng Yancheng Clinical College of Xuzhou Medical University Yancheng People's Republic of China.
Yuexin ChengDepartment of Hematology The First people's Hospital of Yancheng Yancheng Clinical College of Xuzhou Medical University Yancheng People's Republic of China.
Xiaofei YangNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou People's Republic of China.
Suning ChenNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Our study aims to explore the types of diseases that may cause eosinophilia and the changes in the disease spectrum of different degrees of eosinophilia. Methods: We retrospectively analyzed patients who were admitted to the First Affiliated Hospital of Soochow University from July 1, 2023 to June 30, 2024, and had at least twice eosinophilia (absolute eosinophil count [ACE] > 0.5 × 109/L, the interval between the two tests was ≥ 3 days). Eosinophilia was classified as mild (1.5 × 109/L ≥ ACE > 0.5 × 109/L), moderate (5 × 109/L ≥ AEC > 1.5 × 109/L), or severe (AEC > 5 × 109/L). Results: A total of 1821 patients were included, with a median age of 56 years (2-96 years), including 1252 males (68.8%) and a median ACE of 1.02 × 109/L (0.53-41.35). Here, 1679 cases were diagnosed with diseases that may be related to eosinophilia, allergic diseases were the most common (21.7%, 364/1679). Eight cases of clonal eosinophilia were diagnosed as myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK). Around 91 patients were diagnosed as idiopathic eosinophilia after a series of screening. Here, 71.7% (1305/1821) of the patients showed mild eosinophilia, allergic diseases (21.7%, 283/1305) were still the main secondary factors, 23.6% (430/1821) of the patients showed moderate eosinophilia, hematological malignancies became the most common secondary factors (20.5%, 88/430), and 86 patients had severe eosinophilia, nearly half (40/86) of the patients were secondary to hematological malignancies. Conclusion: Eosinophilia has a wide range of age, and is more common in males. Allergic diseases are the most common secondary factors. Different levels of eosinophilia have different causes. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.

Indexed as

diagnosiseosinophiliaetiologysecondary factor

Identifiers

PMID42824263
PMCPMC13627256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.